Cargando…

Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?

A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves’ orbitopathy after alemtuzumab conditioning for hematopoietic stem cell transplantation.

Detalles Bibliográficos
Autores principales: Cima, Luminita Nicoleta, Lambrescu, Ioana Maria, Stejereanu, Lavinia, Colita, Anca, Or, Reuven, Fica, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930230/
https://www.ncbi.nlm.nih.gov/pubmed/29744075
http://dx.doi.org/10.1002/ccr3.1486
_version_ 1783319466779607040
author Cima, Luminita Nicoleta
Lambrescu, Ioana Maria
Stejereanu, Lavinia
Colita, Anca
Or, Reuven
Fica, Simona
author_facet Cima, Luminita Nicoleta
Lambrescu, Ioana Maria
Stejereanu, Lavinia
Colita, Anca
Or, Reuven
Fica, Simona
author_sort Cima, Luminita Nicoleta
collection PubMed
description A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves’ orbitopathy after alemtuzumab conditioning for hematopoietic stem cell transplantation.
format Online
Article
Text
id pubmed-5930230
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-59302302018-05-09 Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy? Cima, Luminita Nicoleta Lambrescu, Ioana Maria Stejereanu, Lavinia Colita, Anca Or, Reuven Fica, Simona Clin Case Rep Case Reports A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves’ orbitopathy after alemtuzumab conditioning for hematopoietic stem cell transplantation. John Wiley and Sons Inc. 2018-03-12 /pmc/articles/PMC5930230/ /pubmed/29744075 http://dx.doi.org/10.1002/ccr3.1486 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Cima, Luminita Nicoleta
Lambrescu, Ioana Maria
Stejereanu, Lavinia
Colita, Anca
Or, Reuven
Fica, Simona
Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?
title Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?
title_full Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?
title_fullStr Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?
title_full_unstemmed Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?
title_short Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?
title_sort graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with fanconi anemia – side effect of alemtuzumab therapy?
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930230/
https://www.ncbi.nlm.nih.gov/pubmed/29744075
http://dx.doi.org/10.1002/ccr3.1486
work_keys_str_mv AT cimaluminitanicoleta gravesorbitopathyafterallogeneicbonemarrowtransplantationinapatientwithfanconianemiasideeffectofalemtuzumabtherapy
AT lambrescuioanamaria gravesorbitopathyafterallogeneicbonemarrowtransplantationinapatientwithfanconianemiasideeffectofalemtuzumabtherapy
AT stejereanulavinia gravesorbitopathyafterallogeneicbonemarrowtransplantationinapatientwithfanconianemiasideeffectofalemtuzumabtherapy
AT colitaanca gravesorbitopathyafterallogeneicbonemarrowtransplantationinapatientwithfanconianemiasideeffectofalemtuzumabtherapy
AT orreuven gravesorbitopathyafterallogeneicbonemarrowtransplantationinapatientwithfanconianemiasideeffectofalemtuzumabtherapy
AT ficasimona gravesorbitopathyafterallogeneicbonemarrowtransplantationinapatientwithfanconianemiasideeffectofalemtuzumabtherapy